RecruitingNot ApplicableNCT06506058

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease


Sponsor

University of Minnesota

Enrollment

75 participants

Start Date

Mar 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Currently, there is a lack of comprehensive knowledge about the role of vestibulospinal drive and cortical activity during self-initiated movement transitions in older adults and people with PD (both with and without FOG). This set of experiments has two primary purposes: to (1) understand the pathological neurophysiology underlying freezing of gait (FOG) during movement transitions and FOG-inducing movements and (2) identify neurological biomarkers associated with FOG and FOG-inducing movements. To achieve this, the investigators will assess vestibular activity using the noninvasive neuromodulation technique of electrical vestibular stimulation (EVS, Experiments 1 and 2) and assess cortical activity by recording via electroencephalography (EEG, Experiments 3 and 4, no stimulation included). These experiments will investigate the vestibular (EVS Experiments) and cortical (EEG experiments) contributions to movement transitions during standing, walking, turning, and changing movement rates. Upon completion of this project, the investigators expect to provide a new understanding of key neural systems (vestibular and cortical) involved in the pathogenesis of movement impairment and freezing episodes during movement transitions including gait initiation, turning, and changing movement rates, in people with PD. An increased understanding of the temporal dynamics of systems involved in FOG and FOG-inducing movements could later guide the development and delivery of novel interventions (e.g. closed-loop deep brain stimulation \[DBS\] or non-invasive brain stimulation) to decrease the incidence and severity of FOG episodes, reducing fall risk and morbidity.


Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study examines the brain and balance systems involved in freezing of gait in Parkinson's disease — a sudden inability to move the feet while walking. Using brain recordings and MRI, researchers will compare people with Parkinson's who freeze, those who don't, and healthy adults to understand the underlying mechanisms. **You may be eligible if...** - You have a confirmed diagnosis of idiopathic (typical) Parkinson's disease and are aged 40–80 - You are able to walk at least 50 meters without an assistive device - Healthy older adults (40–80) and young adults (21–44) may also join as comparison participants **You may NOT be eligible if...** - You have a musculoskeletal condition significantly affecting walking - You have uncorrected vision problems that could affect performance - You have a history of vestibular (inner ear balance) or visual conditions - Any other condition that would interfere with study tasks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEVS and EEG

The participant can choose to participate in one or more of the following experiments. (Any two of these visits will be separated by at least one week.) Experiment 1: EVS during gait initiation (forward stepping, 2 visits) Experiment 2: EVS during turning (1 visit) Experiment 3: EEG during gait initiation (forward stepping, 1 visit) Experiment 4: EEG during RAMS (1 visit) vestibular activity will be assessed using the noninvasive neuromodulation technique of electrical vestibular stimulation (EVS, Experiments 1 and 2) and cortical activity will be assessed by recording via electroencephalography (EEG, Experiments 3 and 4, no stimulation included).


Locations(1)

University of Minnesota, Movement Disorders Lab

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06506058


Related Trials